Results 191 to 200 of about 50,140 (235)

Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the FDA Adverse Event Reporting System. [PDF]

Cancer Med
Chen T, Shu K, Xiao H, Yuan Y, Zhang F, Liu Y.   +5 more
europepmc   +1 more source

Single-cell RNA sequencing reveals clonally expanded CD4+ tissue-resident memory T cells in histidyl-tRNA synthetase-induced myositis. [PDF]

JCI Insight
Li D, Reay DP, Pinal-Fernandez I, Casal-Dominguez M, Mammen AL, Gaffen SL, Oriss TB, Ascherman DP.   +7 more
europepmc   +1 more source

Idiopathic inflammatory myopathy-related interstitial lung disease patients present to pulmonology: a tertiary center experience. [PDF]

Ann Am Thorac Soc
Davis AE, Wilson D, Ludtke EA, De Andrade JA, Annapureddy N, Young-Glazer J, Olajide AA, Dudenhofer RB, Hewlett JC, Wilfong EM, MYSTIC Investigators.   +10 more
europepmc   +1 more source

Isolated superior rectus-levator complex enlargement: Inflammatory etiology, clinicoradiological features, and treatment outcomes. [PDF]

PLoS One
Yang MK, Ha SJ, Sa HS.
europepmc   +1 more source

Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report. [PDF]

Front Immunol
Li K, Hu J, Gan Z, Chen J, Tian Y, Luo R, Qi X.   +6 more
europepmc   +1 more source

Animal Models of Idiopathic Inflammatory Myopathies: Bridging Mechanistic Insights and Clinical Translation. [PDF]

Int J Mol Sci
Wang G, Cui S, Yang L, McCullagh KJA, Ma C, Liu A.   +5 more
europepmc   +1 more source

Clinicopathological and serological spectrum of idiopathic inflammatory myopathies: Experience from a neuromuscular referral center in Cyprus. [PDF]

J Neuromuscul Dis
Tsokkos T, Zamba-Papanicolaou E, Papacharalambous R, Taliadoros C, Kleopa KA.   +4 more
europepmc   +1 more source

Immune checkpoint inhibitor-related myositis with hepatitis in HER2-positive metastatic breast cancer after trastuzumab deruxtecan plus sintilimab: a case report. [PDF]

Front Oncol
Long Y, Xiao X, Ji X, Wang Z, Mao H, Liu S.   +5 more
europepmc   +1 more source

Correction: Furlepa et al. Management of Triple M Syndrome: A Systematic Review with Narrative Synthesis of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis, Myositis and Myocarditis. <i>Cancers</i> 2025, <i>17</i>, 2063. [PDF]

Cancers (Basel)
Furlepa M, Watts I, Carr AS.
europepmc   +1 more source

Beyond the respiratory tract: a case of acute viral myositis following respiratory syncytial virus infection. [PDF]

GMS Hyg Infect Control
Kefala-Karli P, Sassis L, Aristodimou A, Dramiotou L, Kostis A.   +4 more
europepmc   +1 more source